Full Name
Dakle Pushkar Pravin
(not current staff)
 
 
Email
csidpp@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF

Results 1-8 of 8 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
12018ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansionMadan, V. ; Han, L. ; Hattori, N.; Woon Teoh, W. ; Mayakonda, A. ; Sun, Q.-Y. ; Ding, L.-W. ; Mohd Nordin, H.B.; Lim, S.L. ; Shyamsunder, P. ; Dakle, P. ; Sundaresan, J.; Doan, N.B.; Sanada, M.; Sato-Otsubo, A.; Meggendorfer, M.; Yang, H. ; Said, J.W.; Ogawa, S.; Haferlach, T.; Liang, D.-C.; Shih, L.-Y.; Nakamaki, T.; Wang, Q.T.; Koeffler, H.P. 
222-Mar-2019Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcomaCHEN YE ; Xu, Liang; Anand Mayakonda Thippeswamy ; Huang, Mo-Li; Kanojia, Deepika; Tan, Tuan Zea ; DAKLE PUSHKAR PRAVIN ; LIN YU-TONG, RUBY ; Ke, Xin-Yu; Said, Jonathan W; Chen, Jianxiang; Gery, Sigal; Ding, L.-W. ; Jiang, Yan-Yi; Pang, Angela; MARK EDWARD PUHAINDRAN ; Boon Cher Goh ; Koeffler, H Phillip
37-Oct-2019Identification of somatic alterations in lipoma using whole exome sequencingKanojia, Deepika ; Dakle, Pushkar ; Mayakonda, Anand ; Parameswaran, Rajeev ; Puhaindran, Mark E ; Min, Victor Lee Kwan ; Madan, Vikas ; Koeffler, Phillip 
49-Feb-2021MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcomaKe, Xin-Yu; Chen, Ye; Tham, Valarie Yu-Yan; Lin, Ruby Yu-Tong; Dakle, Pushkar ; Nacro, Kassoum; Puhaindran, Mark Edward; Houghton, Peter; Pang, Angela; Lee, Victor Kwanmin ; Ding, Ling-Wen ; Gery, Sigal; Hill, Jeffrey; Chen, Leilei; Xu, Liang; Koeffler, H Phillip
526-Aug-2020Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomasJeitany, Maya ; Prabhu, Aishvaryaa; Dakle, Pushkar ; Pathak, Elina; Madan, Vikas ; Kanojia, Deepika ; Mukundan, Vineeth ; Jiang, Yan Yi ; Landesman, Yosef; Tam, Wai Leong ; Kappei, Dennis ; Koeffler, H. Phillip 
62019Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinationsLim, S.L.; Damnernsawad, A.; Shyamsunder, P. ; Chng, W.J. ; Han, B.C.; Xu, L. ; Pan, J.; Pravin, D.P. ; Alkan, S.; Tyner, J.W.; Koeffler, H.P. 
715-Mar-2023Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer ImmunotherapyRan, XB; Ding, LW ; Sun, QY ; Yang, H ; Said, JW; Zhentang, L ; Madan, V ; Dakle, P ; Xiao, JF; Loh, X ; Li, Y ; Xu, L ; Xiang, XQ; Wang, LZ; Goh, BC ; Lin, DC; Chng, WJ ; Tan, SY ; Jha, S ; Koeffler, HP 
81-Feb-2022THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair InhibitorsShyamsunder, Pavithra ; Sridharan, Shree Pooja; Madan, Vikas ; Dakle, Pushkar ; Zeya, Cao; Kanojia, Deepika ; Chng, Wee-Joo ; Ong, S Tiong ; Koeffler, H Phillip